Oric Pharmaceuticals (ORIC)

• Market cap: $879M
• 1 day: -1.62%
• 5 days: 6.93%
• 1 month: 7.06%
• 3 months: -21.82%
• 6 months: 4.94%
• Year to date: 3.92%
• 1 year: -7.92%
• 5 years: -57.51%
• 10 years: -67.05%
• Sector: Healthcare
• Industry: Biotechnology

About: ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Employees: 104